Page last updated: 2024-08-25

3-deazaneplanocin and Scleroderma, Systemic

3-deazaneplanocin has been researched along with Scleroderma, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bogunia-Kubik, K; Ciechomska, M; Maslinski, W; Merdas, M; Morgiel, E; Swierkot, J; Wiland, P; Zarecki, P	1

Other Studies

1 other study(ies) available for 3-deazaneplanocin and Scleroderma, Systemic

Article	Year
The role of microRNA-5196 in the pathogenesis of systemic sclerosis. European journal of clinical investigation, 2017, Volume: 47, Issue:8 Topics: Adenosine; Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Female; Fos-Related Antigen-2; Histone Deacetylase Inhibitors; Humans; Interleukin-8; Leukocytes, Mononuclear; Male; Matrix Metalloproteinases; MicroRNAs; Middle Aged; Oxidative Stress; Peptides, Cyclic; Reactive Oxygen Species; Scleroderma, Systemic; Tissue Inhibitor of Metalloproteinase-1; Toll-Like Receptor 8; Transfection	2017

Article

Year

The role of microRNA-5196 in the pathogenesis of systemic sclerosis.

European journal of clinical investigation, 2017, Volume: 47, Issue:8

Topics: Adenosine; Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Female; Fos-Related Antigen-2; Histone Deacetylase Inhibitors; Humans; Interleukin-8; Leukocytes, Mononuclear; Male; Matrix Metalloproteinases; MicroRNAs; Middle Aged; Oxidative Stress; Peptides, Cyclic; Reactive Oxygen Species; Scleroderma, Systemic; Tissue Inhibitor of Metalloproteinase-1; Toll-Like Receptor 8; Transfection

2017